» Authors » Carlota Garcia-Hoz

Carlota Garcia-Hoz

Explore the profile of Carlota Garcia-Hoz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 400
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Hoz C, Crespo L, Pariente R, De Andres A, Rodriguez-Ramos R, Roy G
Nutrients . 2024 Apr; 16(8). PMID: 38674808
Background: Celiac disease is a gluten-related pathology, highly prevalent and heterogeneous in its clinical presentation, which leads to delays in diagnosis and misdiagnosis. The analysis of duodenal intraepithelial lymphocytes (IELs)...
2.
Moreno-Arrones O, Garcia-Hoz C, Del Campo R, Roy G, Saceda-Corralo D, Jimenez-Cauhe J, et al.
Dermatology . 2023 Jan; 239(3):454-461. PMID: 36716709
Background: Folliculitis decalvans (FD) is a rare primary neutrophilic scarring alopecia whose etiology has not been completely elucidated yet. Objective: The aim of the study was to determine if the...
3.
Roy G, Fernandez-Banares F, Corzo M, Gomez-Aguililla S, Garcia-Hoz C, Nunez C
Front Immunol . 2023 Jan; 13:1081955. PMID: 36713361
Accurate celiac disease (CD) diagnosis is still challenging for some specific patients or circumstances. Thus, much effort has been expended last decades focused on seronegative or low grade enteropathy CD...
4.
Camarero C, De Andres A, Garcia-Hoz C, Roldan B, Muriel A, Leon F, et al.
Clin Transl Gastroenterol . 2021 Nov; 12(11):e00426. PMID: 34757327
Introduction: Quantitative and phenotypic analyses of duodenal intraepithelial lymphocytes (IELs) by flow cytometry (IEL lymphogram) confer specificity and enable the diagnosis even in unconventional presentations of celiac disease (CD). To...
5.
Hernandez-Breijo B, Plasencia-Rodriguez C, Navarro-Compan V, Garcia-Hoz C, Nieto-Ganan I, Sobrino C, et al.
Front Med (Lausanne) . 2021 Jul; 8:683990. PMID: 34222289
Biological therapies, such as TNF inhibitors (TNFi), are increasing remission (REM) rates in rheumatoid arthritis (RA) patients, although these are still limited. The aim of our study was to analyze...
6.
Ponce-Alonso M, Garcia-Hoz C, Halperin A, Nuno J, Nicolas P, Martinez-Perez A, et al.
Front Immunol . 2021 Jun; 12:683387. PMID: 34149723
Fecal microbiota transplantation (FMT) is an effective procedure against infection (CDI), with promising but still suboptimal performance in other diseases, such as ulcerative colitis (UC). The recipient's mucosal immune response...
7.
Rodriguez-Martin E, Nieto-Ganan I, Hernandez-Breijo B, Sobrino C, Garcia-Hoz C, Bachiller J, et al.
Front Immunol . 2020 Sep; 11:1913. PMID: 32973793
TNF inhibitors (TNFis) are widely used for the treatment of rheumatoid arthritis (RA), although the response rates to this therapy in patients with RA remains heterogeneous and < 50% achieve...
8.
Martin-Moro F, Marquet J, Piris M, Michael B, Saez A, Corona M, et al.
Br J Haematol . 2020 May; 190(1):e16-e20. PMID: 32379921
No abstract available.
9.
Garcia-Hoz C, Crespo L, Lopez N, De Andres A, Rios Leon R, Santon A, et al.
Dig Dis . 2020 Feb; 38(6):490-499. PMID: 32015237
Background: Refractory celiac disease type II (RCD-II) is a very rare yet severe complication of celiac disease (CD) with a 50% rate of progression to Enteropathy-associated T-cell lymphoma (EATL). Timely...
10.
Sanchez-Fernandez G, Cabezudo S, Caballero A, Garcia-Hoz C, Tall G, Klett J, et al.
J Biol Chem . 2016 Feb; 291(18):9513-25. PMID: 26887939
Heterotrimeric G proteins play an essential role in the initiation of G protein-coupled receptor (GPCR) signaling through specific interactions with a variety of cellular effectors. We have recently reported that...